Search
Now showing items 1-10 of 21
Article
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV‑2 and Potential Mechanisms
| Date Issued:
2021 | Copyright:
open access
Article
Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARSCoV- 2 variants with high potency
| Date Issued:
2021 | Copyright:
open access
Article
Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2
| Date Issued:
2021 | Copyright:
open access
Article
SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites
| Date Issued:
2021 | Copyright:
open access
Article
Human endogenous retrovirus K in the respiratory tract is associated with COVID‑19 physiopathology
| Date Issued:
2022 | Copyright:
open access
Article
Non-permissive SARS-CoV-2 infection in human neurospheres
| Date Issued:
2021 | Copyright:
open access
Article
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
| Date Issued:
2021 | Copyright:
open access
Article
Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages
| Date Issued:
2023 | Copyright:
open access
Article
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
| Date Issued:
2017 | Copyright:
open access
Article
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
| Date Issued:
2022 | Copyright:
open access